Ethamivan
From Wikipedia, the free encyclopedia
Ethamivan
|
|
Systematic (IUPAC) name | |
N,N-diethyl-4-hydroxy-3-methoxybenzamide | |
Identifiers | |
CAS number | |
ATC code | R07 |
PubChem | |
Chemical data | |
Formula | C12H17NO3 |
Mol. mass | 223.268 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Ethamivan (Etamivan, Analepticon) is a respiratory stimulant drug[1] related to nikethamide. It was mainly used in the treatment of barbiturate overdose[2] and chronic obstructive pulmonary disease,[3] but has now largely fallen into disuse. Some research suggests that it may have abuse potential.[4]
[edit] References
- ^ Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
- ^ Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
- ^ Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.
- ^ Ma C, Duan H, Zhang H, Xu Y, Zhou T. Studies on analytical method for 10 drugs of abuse in urine using HPLC. (Chinese) Yao Xue Xue Bao. 1998 Oct;33(10):764-7.
|